Page 2514 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 152 Hematologic Manifestations of Childhood Illness 2237.e9

influence of concomitant use of mycophenolate mofetil. Transpl Proc Surveillance System, United States, 2002–2010 and National Health
41(3):1047–1049, 2009. and Nutrition Examination Survey, United States, 1999–2010. MMWR
379. Casas-Melley AT, Falkenstein KP, Flynn LM, et al: Improvement in renal Suppl 63:36–42, 2014.
function and rejection control in pediatric liver transplant recipients 395. Ji AL, Wang F, Luo WJ, et al: Lead poisoning in China: a nightmare
with the introduction of sirolimus. Pediatr Transplant 8(4):362–366, from industrialisation. Lancet 377(9776):1474–1476, 2011.
2004. 396. Canfield RL, Henderson CR, Jr, Cory-Slechta DA, et al: Intellectual
380. Lobach NE, Pollock-Barziv SM, West LJ, et al: Sirolimus immuno- impairment in children with blood lead concentrations below 10 µg
suppression in pediatric heart transplant recipients: a single-center per deciliter. N Engl J Med 348(16):1517–1526, 2003.
experience. J Heart Lung Transplant 24(2):184–189, 2005. 397. Campbell C, Osterhoudt KC: Prevention of childhood lead poisoning.
381. De Bruyne RM, Dhawan A: Bone marrow dysfunction following Curr Opin Pediatr 12(5):428–437, 2000.
pediatric liver transplantation. Pediatr Transplant 9(4):423–426, 2005. 398. Ivascu NS, Sarnaik S, McCrae J, et al: Characterization of pica preva-
382. Rajwal SR, Davison SM, Stringer MD, et al: Successful recovery of lence among patients with sickle cell disease. Arch Pediatr Adolesc Med
aplastic anemia following orthotopic liver transplantation for non-A-E 155:1243, 2001.
acute liver failure. Pediatr Transplant 9(4):537–540, 2005. 399. Issaivanan M, Ahmed R, Shekher M, et al: Sickle cell disease and
383. Pirkle JL, Brody DJ, Gunter EW, et al: The decline in blood lead levels plumbism in children. Pediatr Blood Cancer 52:653, 2009.
in the United States: the National Health and Nutrition Examination 400. Lachant NA, Tomoda A, Tanaka KR: Inhibition of the pentose phos-
Surveys (NHANES). JAMA 272(4):284–291, 1994. phate shunt by lead: a potential mechanism for hemolysis in lead
384. Nosari A, Marbello L, De Carlis LG, et al: Bone marrow hypoplasia poisoning. Blood 63(3):518–524, 1984.
complicating tacrolimus (FK506) therapy. Int J Hematol 79(2):130–132, 401. Markowitz ME, Rosen JF, Bijur PE: Effects of iron deficiency on
2004. lead excretion in children with moderate lead intoxication. J Pediatr
385. Karras A, Thervet E, Legendre C: Hemophagocytic syndrome in 116(3):360–364, 1990.
renal transplant recipients: report of 17 cases and review of literature. 402. Cohen AR, Trotzky MS, Pincus D: Reassessment of the microcytic
Transplantation 77(2):238–243, 2004. anemia of lead poisoning. Pediatrics 67(6):904–906, 1981.
386. Sauter D, Goldfrank L: Hematologic aspects of toxicology. Hematol 403. Yip R, Norris TN, Anderson AS: Iron status of children with elevated
Oncol Clin North Am 1(2):335–349, 1987. blood lead concentrations. J Pediatr 98(6):922–925, 1981.
387. Tenenbein M, Israels SJ: Early coagulopathy in severe iron poisoning. 404. Clark M, Royal J, Seeler R: Interaction of iron deficiency and lead
J Pediatr 113(4):695–697, 1988. and the hematologic findings in children with severe lead poisoning.
388. Avner JR, Henretig FM, McAneney CM: Acquired methemoglobin- Pediatrics 81(2):247–254, 1988.
emia: the relationship of cause to course of illness. Am J Dis Child 405. Piomelli S: Childhood lead poisoning. Pediatr Clin North Am
144(11):1229–1230, 1990. 49(6):1285, 2002.
389. Yano SS, Danish EH, Hsia YE: Transient methemoglobinemia with 406. Scriver CR, Beaudet AL, Sly WS, et al, editors: The metabolic basis of
acidosis in infants. J Pediatr 100(3):415–418, 1982. inherited disease, ed 7, New York, 1995, McGraw-Hill.
390. Hanukoglu A, Danon PN: Endogenous methemoglobinemia associated 407. McIntyre OR, Ebaugh FG, Jr: Palpable spleens in college freshmen.
with diarrheal disease in infancy. J Pediatr Gastroenterol Nutr 23(1):1–7, Ann Intern Med 66(2):301–306, 1967.
1996. 408. Odom LF, Tubergen DG: Splenomegaly in children: identifying the
391. Pollack ES, Pollack CV, Jr: Incidence of subclinical methemoglobinemia cause. Postgrad Med 65(4):191, 1979.
in infants with diarrhea. Ann Emerg Med 24(4):652–656, 1994. 409. Bader-Meunier B, Gauthier F, Archambaud F, et al: Long-term evalu-
392. Kumar AR, Dunn N, Naqvi M: Methemoglobinemia associated with a ation of the beneficial effect of subtotal splenectomy for management
prilocaine-lidocaine cream. Clin Pediatr (Phila) 36(4):239–240, 1997. of hereditary spherocytosis. Blood 97(2):399–403, 2001.
393. Curry S: Methemoglobinemia. Ann Emerg Med 11(4):214–221, 1982. 410. Rice HE, Oldham KT, Hillery CA, et al: Clinical and hematologic
394. Raymond J, Wheeler W, Brown MJ, et al: Lead screening and preva- benefits of partial splenectomy for congenital hemolytic anemias in
lence of blood lead levels in children aged 1-2 years—Child Blood Lead children. Ann Surg 237(2):281–288, 2003.